Results of Meeting

EBOS Group Limited. NZBN 9429031998840
108 Wrights Road, Christchurch, New Zealand, 8024
Level 7, 737 Bourke Street, Docklands, Victoria 3008, Australia
Phone: +61 3 9918 5555, Fax: +61 3 9918 5588.
www.ebosgroup.com


27 October 2022
NZX/ ASX Code: EBO
Results of EBOS Group Limited Annual Meeting

At EBOS Group Limited’s shareholder meeting, held in Auckland and online today, shareholders were
asked to vote on three resolutions, which were supported by the Board.
As required by NZX Listing Rule 6.1, all voting was conducted by a poll.
The resolutions passed by shareholders were:
• the election of Mark Bloom;
• the re-election of Stuart McLauchlan; and
• auditor’s remuneration.

Detail of the total number of votes cast in person or by a proxy holder are:
Resolution For Against Abstain
It is resolved that Mark Bloom be
elected as a director of the Company.
115,504,239
99.81%

220,104
0.19%

18,873
It is resolved that Stuart McLauchlan be
re-elected as a director of the Company.
114,629,677
99.05%

1,099,457
0.95%

14,082
It is resolved that the directors of the
Company be authorised to fix the fees
and expenses of Deloitte as auditor of
the Company.
114,521,325
98.97%

1,187,828
1.03%

34,010

EBOS Group Limited. NZBN 9429031998840
108 Wrights Road, Christchurch, New Zealand, 8024
Level 7, 737 Bourke Street, Docklands, Victoria 3008, Australia
Phone: +61 3 9918 5555, Fax: +61 3 9918 5588.
www.ebosgroup.com

The following information is provided as required under ASX Listing Rule 3.13.2(e):
Valid proxies received prior to
meeting
Resolution
For Against Discretionary Abstain
It is resolved that Mark Bloom
be elected as a director of the
Company.
113,575,750 211,480 1,539,037 18,873
It is resolved that Stuart
McLauchlan be re-elected as a
director of the Company.
112,688,264 1,099,457 1,543,337 14,082
It is resolved that the directors
of the Company be authorised
to fix the fees and expenses of
Deloitte as auditor of the
Company.
112,619,304 1,187,828 1,528,409 9,599


Authority for this announcement
Name of person authorised to make this
announcement
Janelle Cain
Contact person for this announcement Janelle Cain
Contact phone number +61 3 9918 5555
Contact email address janelle.cain@ebosgroup.com
Date of release through MAP 27 October 2022